The research group placed miniscule particles of iron inside stem cells to act as cellular beacons detected by magnetic resonance imaging. With the ability to monitor where the human stem cells go in real time, researchers will have an easier time learning the best way of using the cells to treat human neural disorders, such as stroke, traumatic brain injury, Parkinson's disease or radiation damage.
The findings, to be published in the June 4 advance online version of the Proceedings of the National Academy of Sciences, could eventually make it possible to track human stem cells that are transplanted into the brains of patients.
Gary Steinberg, MD, PhD, who led the research group, said the work also shows that the iron doesn't disrupt the normal function of the stem cells. "This work is important because if a method of tracking the cells changes their biology, it will not be helpful," said Steinberg, senior author of the paper and the Bernard and Ronni Lacroute-William Randolph Hearst Professor in Neurosurgery and Neurosciences.
In a 2006 study, Steinberg and his colleagues had shown that the same human stem cells used in this study were able to migrate toward a brain region in rats that mimicked a human stroke. They also found that those cells matured into the types of cells they would expect to find in that part of the brain.
The only problem was that in order to find out where the cells ended up, they had to kill the rats - not an approach that can be used for human clinical trials. What the researchers needed was a way of tracking the stem cells in real time to find out whether cells migrated appropriately and survived.
Steinberg said that the iron particles, called superparamagnetic iron oxide or SPIO, have been used for more than a decade to track cells in living animals, including in rat neural stem cells. If the point is to use the technique in humans, he and postdoctoral scholar Raphael Guzman, MD, wanted to make sure that the particles worked in human cells as well.
"I think it's critical that we are applying this technique in human stem cells that can be used in human clinical trials," said Guzman, who is lead author of the paper. He said that because they chose to work with those cells, their results can be directly translated to human trials.
They were reassured that putting the iron particles in the cells didn't change the stem cells' biological properties. Also, when the group placed those iron-filled human neural stem cells into the brains of rats - either healthy fetal and adult rats or those that had experienced a stroke - the cells behaved as expected in each case.
In fetal mice with brains still developing, the group injected stem cells into the fluid-filled brain regions called ventricles. From there, the iron-filled cells migrated along the path that stem cells normally take to populate the developing brain. Those stem cells also matured into the proper types of brain cells.
In adult rats that had a simulated stroke, the human stem cells migrated into the damaged region, matured into the appropriate type of neuron and support cells and appeared to integrate into the surrounding tissue. The research group is currently testing whether those transplanted cells repaired stroke-induced damage to the rats' ability to move or learn.
The only situation that rendered the neural stem cells immobile was the healthy adult rat brain. As with Steinberg's previous work, the group found that in the absence of any signals to beckon the stem cells, they stayed close to where the researchers implanted them.
All of this adds up to encouraging news for researchers hoping to use stem cells to treat human disease. For now, nobody knows the best way of inserting the cells, the conditions that are best for cell survival, or the optimal timing after an injury for when transplanting the cells is most effective. With the ability to watch the cells in real time, researchers can compare different techniques to learn what works best.
The cells used in this study were similar to those that are part of a clinical trial for a childhood disorder called Batten's disease. Steinberg said he and others are interested in testing these or other stem cells as a way of treating a wide range of diseases.
Amy Adams | EurekAlert!
Unique genome architectures after fertilisation in single-cell embryos
30.03.2017 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH
Transport of molecular motors into cilia
28.03.2017 | Aarhus University
The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.
To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
29.03.2017 | Materials Sciences
29.03.2017 | Physics and Astronomy
29.03.2017 | Earth Sciences